- Category
- Micro (2024-25)
- Udyam number
- UDYAM-MH-19-0157596

Mafrix Pharmaceuticals Private Limited
About Mafrix Pharmaceuticals Private Limited
Data last updated:
Mafrix Pharmaceuticals Private Limited is a private limited company based in Mumbai, Maharashtra, India. It operates in the drug formulation and development segment of the pharmaceuticals sector. It was incorporated on 23 August 2022.
The company is registered with the Registrar of Companies (ROC), Mumbai, under CIN U24230MH2022PTC389046.
The company has an authorised share capital of ₹5 Lakh and a paid-up capital of ₹1 Lakh. It is led by directors Mohammed Mursaleen Farooqui and Sajid Rais Shaikh.
Its last annual general meeting (AGM) was held on 30 September 2025, and its latest financial statements are for the year ended 31 March 2025. The registered office is at 17 Floor – Grd Plot – 335 C Nagree Apartment Dharavi Main Road, Mumbai, Maharashtra, India – 400017.
As per the financials filed for FY 2025, the company reported a revenue of ₹32.26 Lakh, a growth of 38% compared to the previous year. For the same year it recorded a net loss of ₹10.27 Lakh (net margin -31.8%) and EBITDA of -₹9.45 Lakh (EBITDA margin -29.3%).
Mafrix Pharmaceuticals Private Limited is registered as a micro enterprise under the Udyam registration framework (Reg. No. UDYAM-MH-19-0157596).
Company details
Recognitions & Rankings of Mafrix Pharmaceuticals
Contact details
Mafrix Pharmaceuticals Private Limited's registered office is in Mumbai, Maharashtra.
- Registered Address17 Floor – Grd Plot – 335 C Nagree Apartment Dharavi Main Road, Mumbai, Maharashtra, India – 400017
- IndustryPharma, Drug Formulation & Development
- Company details, directors and signatories
- Historical financials and ratios
- Shareholding pattern and group structure
- Charges with holder and property details
- Legal cases, compliance and MCA filings
Business activity
The main business activity of Mafrix Pharmaceuticals is trade. In detail, this covers retail trading.
| Main activity group code | Main activity | Business activity code | Business activity | Share of turnover |
|---|---|---|---|---|
| G | Trade | G2 | Retail Trading |
To see the full business activity and turnover split of Mafrix Pharmaceuticals Private Limited, buy the company report.
Financials of Mafrix Pharmaceuticals Private Limited
FY 2025 filings availableMafrix Pharmaceuticals Private Limited reported revenue of ₹32.26 Lakh (up 38% YoY) for FY 2025.
Compounded Annual Growth Rate (CAGR)
Revenue rose 38% in the latest year. All are worked out from the filed statements.
Financial Statement Summary
| Metrics | FY 2024-25 | FY 2023-24 | FY 2022-23 |
|---|---|---|---|
| Profit and Loss Statement | |||
| Revenue from Operations | |||
| Other Income | |||
| Total Revenue | |||
| Cost of Materials Consumed | |||
| Employee Benefit Expense | |||
| Finance Costs | |||
| Depreciation and Amortisation | |||
| Other Expenses | |||
| Total Expenses | |||
| EBITDA | -₹9.45 Lakh | ||
| Profit Before Tax | |||
| Tax Expense | |||
| Net Profit (PAT) | -₹10.27 Lakh | ||
| Balance Sheet | |||
| Share Capital | |||
| Reserves and Surplus | |||
| Net Worth (Total Equity) | |||
| Long-term Borrowings | |||
| Short-term Borrowings | |||
| Trade Payables | |||
| Total Liabilities | |||
| Fixed Assets | |||
| Investments | |||
| Inventories | |||
| Trade Receivables | |||
| Cash and Bank Balance | |||
| Total Assets | |||
Financial Ratios
| Metrics | FY 2024-25 | FY 2023-24 | FY 2022-23 |
|---|---|---|---|
| Profitability | |||
| EBITDA Margin | -29.3% | ||
| Net Profit Margin | -31.8% | ||
| Return on Equity (ROE) | |||
| Return on Capital Employed (ROCE) | |||
| Return on Assets (ROA) | |||
| Liquidity and Debt | |||
| Current Ratio | |||
| Quick Ratio | |||
| Debt-to-Equity Ratio | |||
| Interest Coverage Ratio | |||
| Efficiency and Growth | |||
| Asset Turnover | |||
| Receivable Days | |||
| Payable Days | |||
| Inventory Days | |||
| Revenue Growth | |||
| Net Profit Growth | |||
To see the full financial statements and ratios of Mafrix Pharmaceuticals Private Limited, buy the company report.
Board of directors of Mafrix Pharmaceuticals Private Limited
Mafrix Pharmaceuticals has 2 current directors and 1 former director. Current directors are listed first, with their designation and appointment date.
| Name | Designation | Appointment Date | Tenure | Status |
|---|---|---|---|---|
| Mohammed Mursaleen Farooqui | Director | 23 Aug 2022 | 4 Years 2 Months | Current |
| Sajid Rais Shaikh | Director | 23 Aug 2022 | 4 Years 2 Months | Current |
Legal cases
No court or tribunal cases involving Mafrix Pharmaceuticals Private Limited are on our record; a case search with case numbers, parties and status is in the company report Buy the company report.
MSME payment delays
No delayed payments to MSME suppliers are on our record for Mafrix Pharmaceuticals Private Limited; the supplier-wise MSME Form 1 check is in the company report Buy the company report.
GST
No GST registration is on our record for Mafrix Pharmaceuticals Private Limited; the GSTIN and return-filing check is in the company report Buy the company report.
Recent activity
Mafrix Pharmaceuticals Private Limited has 3 board changes on record since 2022: 2 appointments and 1 cessation. The latest: Mohd Rizwan Farooqui ceased to be Director on 29 Apr 2025.
Frequently asked questions
Mafrix Pharmaceuticals is an active private limited company based in Mumbai, Maharashtra, India. The company works in drug formulation and development, within the pharma industry. It was incorporated on 23 August 2022 (4+ years old) and is registered under CIN U24230MH2022PTC389046.
Mafrix Pharmaceuticals has 2 current directors:
- Mohammed Mursaleen Farooqui - Director
- Sajid Rais Shaikh - Director
The latest financial statements of Mafrix Pharmaceuticals on record with the MCA are for the year ended 31 March 2025. Its last annual general meeting was held on 30 September 2025. Year-wise statements from FY 2023 are in the company report.
The CIN (Corporate Identification Number) of Mafrix Pharmaceuticals is U24230MH2022PTC389046. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.
Mafrix Pharmaceuticals was incorporated on 23 August 2022, making it 4+ years old. It is registered with the Registrar of Companies, Mumbai.
Mohd Rizwan Farooqui ceased to be Director on 29 Apr 2025. Mohammed Mursaleen Farooqui was appointed as Director on 23 Aug 2022. Sajid Rais Shaikh was appointed as Director on 23 Aug 2022.
Yes, Mafrix Pharmaceuticals is registered as a micro enterprise under Udyam registration (number: UDYAM-MH-19-0157596).
The registered office of Mafrix Pharmaceuticals is at 17 Floor – Grd Plot – 335 C Nagree Apartment Dharavi Main Road, Mumbai, Maharashtra, India – 400017.
Mafrix Pharmaceuticals operates in the pharma industry, in the drug formulation and development segment.
Mafrix Pharmaceuticals can be reached at its registered office: 17 Floor – Grd Plot – 335 C Nagree Apartment Dharavi Main Road, Mumbai, Maharashtra, India – 400017.